Macitentan
Drug timelines are a Plus or Pro feature.
38 regulatory and trial events tracked for Macitentan, covering 2014-02-17 to 2026-06-05. Get the full timeline:
Most recent: Clinical Trial Update: Outcome Study Assessing a 75 Milligrams (mg) Dose of Macitentan in Patients With Pulmonary Arterial Hypertension [Phase 3]